FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia

One‐third of newly diagnosed adult acute myeloid leukaemia (AML) carry FLT3 mutations, which frequently occur together with nucleophosmin (NPM1) mutations and are associated with worse prognosis. FLT3 inhibitors are widely used in clinics with limitations due to drug resistance. AML cells carrying FLT3 mutations in both mouse models and patients present low expression of GATA1, a gene involved in haematopoietic changes preceding AML. Here, we show that FLT3 inhibition induces cellular responses and restores the GATA1 pathway and functions in NPM1/FLT3‐ITD mutated AML, thus providing a new mechanism of action for this drug.

[1]  B. Falini,et al.  How I diagnose and treat NPM1-mutated AML. , 2020, Blood.

[2]  A. Krämer,et al.  Clinical Outcomes in Patients With FLT3-ITD-Mutated Relapsed/Refractory Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplant After Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  B. Falini,et al.  NPM1-mutated acute myeloid leukemia: from bench to bedside. , 2020, Blood.

[4]  V. Deleuze,et al.  Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. , 2020, Blood.

[5]  T. Haferlach,et al.  GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations , 2019, Leukemia.

[6]  A. Fathi,et al.  The role of FLT3 inhibitors in the treatment of FLT3‐mutated acute myeloid leukemia , 2017, European journal of haematology.

[7]  M. Konopleva,et al.  Reversal of Acquired Drug Resistance in FLT3-Mutated Acute Myeloid Leukemia Cells via Distinct Drug Combination Strategies , 2014, Clinical Cancer Research.

[8]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[9]  N. Bolli,et al.  The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. , 2013, Blood.

[10]  J. Martínez-López,et al.  Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF) , 2012, Cancer Cell International.

[11]  Masayuki Yamamoto,et al.  GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis , 2005, Molecular and Cellular Biology.

[12]  Paola Fazi,et al.  Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. , 2005, The New England journal of medicine.

[13]  D. Small,et al.  Mutant FLT3 signaling contributes to a block in myeloid differentiation , 2005, Leukemia & lymphoma.

[14]  H. Kaneko,et al.  Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. , 1996, Leukemia.